A detailed history of Fiduciary Alliance LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Fiduciary Alliance LLC holds 7,278 shares of NVO stock, worth $637,916. This represents 0.11% of its overall portfolio holdings.

Number of Shares
7,278
Previous 6,767 7.55%
Holding current value
$637,916
Previous $968 Million 10.43%
% of portfolio
0.11%
Previous 0.16%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$119.07 - $145.42 $60,844 - $74,309
511 Added 7.55%
7,278 $867 Million
Q2 2024

Jul 09, 2024

BUY
$122.71 - $146.91 $23,069 - $27,619
188 Added 2.86%
6,767 $968 Million
Q1 2024

Apr 17, 2024

BUY
$102.11 - $135.92 $671,781 - $894,217
6,579 New
6,579 $839 Million
Q2 2023

Jul 18, 2023

BUY
$155.98 - $172.65 $6,395 - $7,078
41 New
41 $6.64 Million
Q4 2022

Jan 19, 2023

BUY
$102.55 - $135.33 $2,768 - $3,653
27 New
27 $3.65 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fiduciary Alliance LLC Portfolio

Follow Fiduciary Alliance LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Alliance LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Alliance LLC with notifications on news.